Antibiotics

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses the economic opportunities driving the development of new pharmaceuticals.

Researchers in the United Kingdom have found that predatory bacteria can be used to safely treat antibiotic-resistant Shigella infections, which affect more than 1 million people worldwide each year.

Two cases of meningococcal disease strain B have been confirmed at Oregon State University, urging officials to take preventive measures.

Barry Kreiswirth, PhD, founding director, Public Health Research Institute Tuberculosis Center, professor of medicine at Rutgers University, examines the difficulty of developing new, effective antibiotics as more and more bacteria continue to develop resistance.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic stewardship programs are impacting antibiotic resistance.

On their quest to put an end to a threat that may change modern medicine as we know it, researchers discovered four chemicals that disrupt AcrA, an efflux pump protein, that contributes to antibiotic resistance in bacteria.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses future applications of immunotherapy.

In mid-November, the CDC released the “Core Elements of Outpatient Antibiotic Stewardship.”

A study of 100 chickens collected from a marketplace in India finds multidrug-resistance in an emerging bacterial pathogen, and has researchers calling for improved food safety, monitoring, and surveillance.

A troubling new study has reported the presence of genes that are resistant to antibiotics in air pollution.

In a new approach to fighting bacterial pathogens, Johns Hopkins University researchers have developed a new antibiotic intended to fight tuberculosis and other drug-resistant infections.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how public health institutions can work alongside private pharmaceutical companies to prevent antibiotic resistance.

A recent study has found that the rate of multidrug-resistant Pseudomonas aeruginosa infections is increasing in children in the United States.

A new service in the United Kingdom, made possible by the National Health Service, reportedly offers a fast and accurate diagnosis of bacterial throat infections, promising a new way to reduce unnecessary antibiotic prescriptions.

Researchers have found that molecules left on a individual's phone can reveal a good deal about his/her lifestyle.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic stewardship programs in both the hospital and outpatient settings.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, explains what antibiotic stewardship is and what ideal antibiotic stewardship programs in hospitals look like.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, warns of the potential downsides to taking antibiotics.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, explains how antibiotics can be harmful if they are not used appropriately.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, compares antibiotic prescribing data in the United States to data in Europe.

In a new study, researchers from the United Kingdom have found that cystic fibrosis patients are more likely to pick up multi-drug resistant infections in hospitals than was previously believed.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic prescribing data vary across the United States.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, talks about the importance of educating patients on antibiotic use.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic prescribing data, with an emphasis on outpatient settings.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses “Get Smart About Antibiotics Week” and partnerships with international organizations.

European researchers have found that bacterial DNA molecules called plasmids are driving the evolution of antibiotic resistance in ways previously unknown.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses the threat of antibiotic resistance.

Emergency room providers are misdiagnosing too many patients with cellulitis, according to a new study, causing unnecessary hospitalizations and inappropriate antibiotic use.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains how his team identified national projections of drug-resistant pathogens.

The scope of multidrug-resistant tuberculosis in West Africa, until recently, has not been well-understood, but a new study on eight countries in the region shows that the superbug is more common than previous estimates suggested.